ImageneBio (IMA) Share-based Compensation (2020 - 2024)
Historic Share-based Compensation for ImageneBio (IMA) over the last 5 years, with Q4 2024 value amounting to $5.3 million.
- ImageneBio's Share-based Compensation rose 20170.94% to $5.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $9.6 million, marking a year-over-year increase of 2568.13%. This contributed to the annual value of $5.3 million for FY2024, which is 3062.11% down from last year.
- As of Q4 2024, ImageneBio's Share-based Compensation stood at $5.3 million, which was up 20170.94% from $1.0 million recorded in Q3 2024.
- Over the past 5 years, ImageneBio's Share-based Compensation peaked at $5.3 million during Q4 2024, and registered a low of $354000.0 during Q2 2020.
- For the 5-year period, ImageneBio's Share-based Compensation averaged around $1.6 million, with its median value being $1.7 million (2021).
- Its Share-based Compensation has fluctuated over the past 5 years, first skyrocketed by 25649.72% in 2021, then crashed by 4909.91% in 2024.
- Over the past 5 years, ImageneBio's Share-based Compensation (Quarter) stood at $650000.0 in 2020, then skyrocketed by 143.23% to $1.6 million in 2021, then rose by 17.58% to $1.9 million in 2022, then fell by 5.59% to $1.8 million in 2023, then surged by 201.71% to $5.3 million in 2024.
- Its Share-based Compensation was $5.3 million in Q4 2024, compared to $1.0 million in Q3 2024 and $1.3 million in Q2 2024.